| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00213-014-3669-0 |
| P2888 | exact match | https://scigraph.springernature.com/pub.10.1007/s00213-014-3669-0 |
| P932 | PMC publication ID | 5990001 |
| P698 | PubMed publication ID | 25056852 |
| P5875 | ResearchGate publication ID | 264201979 |
| P50 | author | Coral Barbas | Q28745544 |
| Michel Bernier | Q54311957 | ||
| Rodrigo Machado-Vieira | Q56856236 | ||
| Ruin Moaddel | Q88017241 | ||
| Irving W Wainer | Q96096597 | ||
| Marc C Torjman | Q104720592 | ||
| Carlos A Zarate Jr | Q114131210 | ||
| David A Luckenbaugh | Q114238360 | ||
| Nancy E Brutsche | Q114238371 | ||
| Anuradha Ramamoorthy | Q114575154 | ||
| P2093 | author name string | Ying Xie | |
| Alma Villaseñor | |||
| Antonia Garcia | |||
| Maria Paz Lorenzo | |||
| P2860 | cites work | Antidepressant effects of ketamine: mechanisms underlying fast-acting novel antidepressants | Q21129276 |
| Long-term potentiation depends on release of D-serine from astrocytes | Q33595366 | ||
| Depression and bipolar disorder: relationships to impaired fatty acid and phospholipid metabolism and to diabetes, cardiovascular disease, immunological abnormalities, cancer, ageing and osteoporosis. Possible candidate genes | Q33682541 | ||
| (R,S)-Ketamine metabolites (R,S)-norketamine and (2S,6S)-hydroxynorketamine increase the mammalian target of rapamycin function. | Q33770827 | ||
| Do the dissociative side effects of ketamine mediate its antidepressant effects? | Q33787133 | ||
| Glutamate receptor antagonists as fast-acting therapeutic alternatives for the treatment of depression: ketamine and other compounds. | Q33874459 | ||
| Decreased serum levels of D-serine in patients with schizophrenia: evidence in support of the N-methyl-D-aspartate receptor hypofunction hypothesis of schizophrenia. | Q33966453 | ||
| Capillary electrophoresis-laser-induced fluorescence (CE-LIF) assay for measurement of intracellular D-serine and serine racemase activity | Q34061483 | ||
| Effects of D-amino acid oxidase inhibition on memory performance and long-term potentiation in vivo | Q34286452 | ||
| Brain-specific Phgdh deletion reveals a pivotal role for L-serine biosynthesis in controlling the level of D-serine, an N-methyl-D-aspartate receptor co-agonist, in adult brain. | Q34438746 | ||
| Glycine and a glycine dehydrogenase (GLDC) SNP as citalopram/escitalopram response biomarkers in depression: pharmacometabolomics-informed pharmacogenomics | Q34555598 | ||
| Influence of body fat distribution on free fatty acid metabolism in obesity | Q34570120 | ||
| Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial | Q34655680 | ||
| L-serine synthesis in the central nervous system: a review on serine deficiency disorders | Q35016184 | ||
| Clinical predictors of ketamine response in treatment-resistant major depression | Q35026766 | ||
| Genetic polymorphisms in fatty acid metabolism genes and colorectal cancer | Q35714424 | ||
| Relationship of ketamine's plasma metabolites with response, diagnosis, and side effects in major depression | Q36233963 | ||
| D-Serine Production, Degradation, and Transport in ALS: Critical Role of Methodology | Q36279687 | ||
| Identification and validation of urinary metabolite biomarkers for major depressive disorder | Q36508139 | ||
| Rapid onset of antidepressant action: a new paradigm in the research and treatment of major depressive disorder | Q37147173 | ||
| Plasma amino acids changes in complex regional pain syndrome | Q37329155 | ||
| Psychological effects of ketamine in healthy volunteers. Phenomenological study | Q37338708 | ||
| Nicotinic acetylcholine receptor antagonists alter the function and expression of serine racemase in PC-12 and 1321N1 cells | Q37355749 | ||
| Development and validation of a sensitive LC-MS/MS method for the determination of D-serine in human plasma | Q37418711 | ||
| The involvement of the NMDA receptor D-serine/glycine site in the pathophysiology and treatment of schizophrenia | Q37583070 | ||
| Neurocognitive effects of ketamine in treatment-resistant major depression: association with antidepressant response. | Q37634301 | ||
| A pilot study of plasma metabolomic patterns from patients treated with ketamine for bipolar depression: evidence for a response-related difference in mitochondrial networks | Q37686306 | ||
| Metabolic control analysis of mammalian serine metabolism | Q37825022 | ||
| Inhibition of human serine racemase, an emerging target for medicinal chemistry. | Q37835325 | ||
| NMDA receptor activation: two targets for two co-agonists | Q38079762 | ||
| Plasma levels of D-serine in Brazilian individuals with schizophrenia | Q48337510 | ||
| Synaptic and extrasynaptic NMDA receptors are gated by different endogenous coagonists | Q48419613 | ||
| Serum levels of excitatory amino acids, serine, glycine, histidine, threonine, taurine, alanine and arginine in treatment-resistant depression: modulation by treatment with antidepressants and prediction of clinical responsivity. | Q54139906 | ||
| Plasma concentrations of excitatory amino acids, serine, glycine, taurine and histidine in major depression | Q56767496 | ||
| Correlation between plasma levels of glutamate, alanine and serine with severity of depression | Q83364115 | ||
| P433 | issue | 2 | |
| P921 | main subject | biomarker | Q864574 |
| D-Serine | Q27077119 | ||
| P304 | page(s) | 399-409 | |
| P577 | publication date | 2014-07-24 | |
| P1433 | published in | Psychopharmacology | Q1422802 |
| P1476 | title | D-serine plasma concentration is a potential biomarker of (R,S)-ketamine antidepressant response in subjects with treatment-resistant depression | |
| P478 | volume | 232 |
| Q27028050 | A brief history of the development of antidepressant drugs: from monoamines to glutamate |
| Q85729034 | A chronobiological perspective on ketamine's antidepressant efficacy |
| Q47741629 | A single dose of S-ketamine induces long-term antidepressant effects and decreases oxidative stress in adulthood rats following maternal deprivation. |
| Q38907471 | A translational approach for NMDA receptor profiling as a vulnerability biomarker for depression and schizophrenia |
| Q47660018 | Alterations in amino acid levels in mouse brain regions after adjunctive treatment of brexpiprazole with fluoxetine: comparison with (R)-ketamine. |
| Q55058527 | Are basal D-serine plasma levels a predictive biomarker for the rapid antidepressant effects of ketamine and ketamine metabolites? |
| Q47820012 | Blood D-serine levels as a predictive biomarker for the rapid antidepressant effects of the NMDA receptor antagonist ketamine |
| Q61798767 | D-Serine: Potential Therapeutic Agent and/or Biomarker in Schizophrenia and Depression? |
| Q35682184 | Enantioselective inhibition of d-serine transport by (S)-ketamine |
| Q64943206 | Hydroxynorketamine: Implications for the NMDA Receptor Hypothesis of Ketamine's Antidepressant Action. |
| Q48071667 | Increased serum levels of serine enantiomers in patients with depression. |
| Q35994750 | Ketamine Metabolites Enantioselectively Decrease Intracellular D-Serine Concentrations in PC-12 Cells |
| Q55438088 | Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms. |
| Q34475595 | Ketamine and other N-methyl-D-aspartate receptor antagonists in the treatment of depression: a perspective review |
| Q95642618 | Ketamine as an antidepressant: overview of its mechanisms of action and potential predictive biomarkers |
| Q38270646 | Ketamine-an update on its clinical uses and abuses |
| Q34507177 | New targets for rapid antidepressant action |
| Q47666907 | Progress in Elucidating Biomarkers of Antidepressant Pharmacological Treatment Response: A Systematic Review and Meta-analysis of the Last 15 Years |
| Q47706465 | Serine enantiomers as diagnostic biomarkers for schizophrenia and bipolar disorder. |
| Q39006965 | Symptomatology and predictors of antidepressant efficacy in extended responders to a single ketamine infusion |
| Q48229603 | d-Amino Acid Levels in Perfused Mouse Brain Tissue and Blood: A Comparative Study |
Search more.